Iordensstraat 70
NL- 2012 HE Haarlem

tel  +31 (0)6 53 23 69 70


NL 93 ABNA 0
VAT nr. NL 0087 62028 B01
C of C 40596403

Gummed Paper benefits from call for sustainable packaging and product tampering

Gummed paper tapes are increasingly benefiting from the requirements of both, sustainable packaging and the prevention of theft of valuable products during transport. Especially its use by deliveries of E-commerce orders is growing rapidly. Strong properties like being made from renewable resources, 100% recyclability, a starch based adhesive and an integral closure method, strengthen this growth.

These main conclusions were drawn in Sarasota, Florida during the annual Congress of FIPAGO, the International Federation of the gummed paper chain.

Emphasis was put on keeping spread these positive messages on gummed paper tape as the favorite modern and efficient method for closing and sealing boxes. All relevant information is available on the webpage including extended product information for members, customers and policy makers.

Fipago 61 years of age.

FIPAGO ( the abbreviation for Fédération Internationale des fabricants de PApiers GOmmés), founded in 1957 by a group of European producers, has grown to an international Federation of producers, converters and suppliers of gummed paper tape, serving the interests of its members from Europe, India, South-America and USA-Canada

Sarasota, June 2018

New legislation for pharmaceuticals implies an important role for gummed paper tape

Packaging and closing tapes play a dominant role in meeting two major legal provisions for the European pharmaceutical industry: The Falsified Medicines Directive (2011/62/EU) and its derived Commission Delegated Regulation (EU) 2016/161, published this February. Especially gummed paper tape is a major contributer to fulfill the requirements.

These legal provisions supply details on how the authenticity of medicines should be verified and by whom, as well as the characteristics of the safety features. The deadline for pharmaceutical packaging compliance with the Falsified Medicines Directive is 9 February 2019 in the majority of EU member states.

A major element includes that tamper-proof sealed packaging must be used to prevent falsified medicinal products entering the legal supply chain. An estimated 30 billion medicinal packs are sold and handled annually in Europe.

Anti-tampering device has to enable verification of package tampering. CEN standard EN 16679/2014: “Tamper verification features for medicinal product packaging”, serves to define the features used for tamper verification. These features should indicate that the outer packaging of a finished product has been opened or tampered with in order to prevent the unnoticed entry of falsified medicines into the legal supply chain.

The information provided by this standard primarily serves as guidance to pharmaceutical manufacturers and relevant approval and test institutes with respect to testing the suitability of seals, and lays down the following requirements:

  • The tamper-proof seal must not impair the readability of the prescribed information
  • The prescribed packaging text must remain readable after the pack has been opened
  • The application of features to check tampering attempts may lead to an increase of the physical force required to open the packaging but must not substantially aggravate handling and opening the pack
  • The utilization of opening aids, such as special perforations or starter tabs, may be necessary.

In fact, the standard describes the scope of application, the requirements and features of tamper-proof pharmaceutical packaging, and provides specific recommendations for appropriate sealing. Gummed paper tape is the appropriate sealing method to meet these requirements.